Rock Spring Ventures holds first close at £26.3m

The fund was launched in January 2013 and is expected to reach a final close on £50m. It will focus on early-stage life sciences and health technology companies. It was set up to bridge a perceived gap in sector-specific funding in Scotland and the UK.

RSV-EU has plans to form syndicates with international early-stage investors to achieve larger scale investments in the sector. It will also set up business development initiatives for its portfolio companies with its US-based sister fund, RSV-US, and with its operations in north-east Asia.

Investors
Initial investors include the European Investment Fund (EIF); Scottish Enterprise, which invested through the Scottish Investment Bank; Strathclyde Pension Fund; Rock Spring Ventures LPR (SV‐US); and the universities of Glasgow, Edinburgh and Aberdeen. 

Investments
RSV-EU will back early-stage life science technology companies in the UK, including spinouts from universities.

People
Managing partners Sinclair Dunlop and Kyp Sirinakis will manage the fund.
 

 

• Tweet  
• Facebook  
• LinkedIn  
• Google plus  
• Send to  

• Topics
• Venture
• UK / Ireland
• Healthcare
• United Kingdom
• European Investment Fund
• Scottish Enterprise